| Overview |
| bsm-52639r-apc-cy55-100l |
| Calnexin Recombinant Antibody, APC-Cy5.5 Conjugated |
| WB, IF |
| Human |
| Specifications |
| APC-Cy5.5 |
| Rabbit |
| C terminus human Calnexin |
| Recombinant |
| IgG |
| 1mg/ml |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 821 |
| P27824 |
| Calnexin, IP90, Major histocompatibility complex class I antigen-binding protein p88, p90, CANX |
| Calcium-binding protein that interacts with newly synthesized glycoproteins in the endoplasmic reticulum. It may act in assisting protein assembly and/or in the retention within the ER of unassembled protein subunits. It seems to play a major role in the quality control apparatus of the ER by the retention of incorrectly folded proteins. Associated with partial T-cell antigen receptor complexes that escape the ER of immature thymocytes, it may function as a signaling complex regulating thymocyte maturation. Additionally it may play a role in receptor-mediated endocytosis at the synapse. |
| Application Dilution |
| WB |
1:100-500 |
| IF |
1:500-2000 |
Powered by Bioz